Bank Analysts Release New Share Price Targets on These Companies Today

Wall St. Watchdog reveals information about companies for which stock analysts reiterated their ratings on October 17th.

  • Mead Johnson Nutrition (NYSE:MJN): Deutsche Bank reiterated its rating of Buy for this company and changed its price target from $73 to $79. About the company: Mead Johnson Nutrition Company manufactures nutritional products for infants, children, and expectant and nursing mothers. The Company markets its products in North America, Latin America, Europe and Asia.
  • Xilinx (NASDAQ:XLNX): Barclays Capital reiterated its rating of Equal Weight for this company and changed its price target from $36 to $33. About the company: Xilinx, Inc. designs, develops, and markets complete programmable logic solutions. The Company’s solutions include advanced integrated circuits, software design tools, predefined system functions delivered as cores of logic, and field engineering support. Xilinx sells its products through several channels of distribution to customers in the United States and overseas.
  • Waters (NYSE:WAT): Barclays Capital reiterated its rating of Overweight for this company and changed its price target from $95 to $92. About the company: Waters Corporation provides high-performance liquid chromatography products and services. The Company distributes its products worldwide to a wide range of industries such as pharmaceuticals, chemicals, and environmental testing. Waters also designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments and related software products.
  • Thermo Fisher (NYSE:TMO): Barclays Capital reiterated its rating of Overweight for this company and changed its price target from $69 to $64. About the company: Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
  • Textron (NYSE:TXT): Barclays Capital reiterated its rating of Overweight for this company and changed its price target from $32 to $25. About the company: Textron Inc. is a global, multi-industry company with operations in aircraft, defense, industrial products, and finance. The Company’s products include airplanes, helicopters, weapons, and automotive products. Textron’s finance division offers asset based lending, aviation, distribution, golf, and resort finance, as well as structured capital.
  • Qiagen (NASDAQ:QGEN): Barclays Capital reiterated its rating of Overweight for this company and changed its price target from $21 to $15. About the company: QIAGEN N.V. provides sample and assay technologies. The Company’s technologies (in the format of consumables and automated solutions) are used to process biological samples and to analyze analytes contained therein, such as DNA and RNA. QIAGEN provides these technologies to customers conducting molecular diagnostics, applied testing, pharmaceutical R&D and academic research.
  • Lam Research (NASDAQ:LRCX): Barclays Capital reiterated its rating of Overweight for this company and changed its price target from $46 to $49. About the company: Lam Research Corporation manufactures, markets, and services semiconductor processing equipment used in the making of integrated circuits. The Company’s products are used to deposit special films on a silicon wafer and etch away portions of various films to create a circuit design. Lam sells its products around the world.
  • Illumina (NASDAQ:ILMN): Barclays Capital reiterated its rating of Overweight for this company and changed its price target from $65 to $35. About the company: Illumina, Inc. develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.
  • Hologic (NASDAQ:HOLX): Barclays Capital reiterated its rating of Equal Weight for this company and changed its price target from $20 to $17. About the company: Hologic, Inc. develops, manufactures, and markets x-ray systems. The Company makes x-ray bone densitometers that measure the precise bone density for use in the diagnosing of metabolic bone diseases such as osteoporosis.
  • Gen-Probe (NASDAQ:GPRO): Barclays Capital reiterated its rating of Overweight for this company and changed its price target from $70 to $67. About the company: Gen-Probe Incorporated develops, manufactures, and commercializes diagnostic products based on its genetic probe technologies. The company’s products are used for the clinical diagnosis of human diseases and for screening donated human blood. Clinical diagnostic products are marketed to laboratories and public health institutions in the United States and Canada.
  • Altera (NASDAQ:ALTR): Barclays Capital reiterated its rating of Overweight for this company and changed its price target from $46 to $42. About the company: Altera Corporation designs, manufactures, and markets programmable logic devices and associated development tools. The Company’s products, include a variety of programmable logic devices and hardcopy application-specific integrated circuits.
  • Agilent (NYSE:A): Barclays Capital reiterated its rating of Overweight for this company and changed its price target from $49 to $44. About the company: Agilent Technologies, Inc. provides core bio-analytical and electronic measurement solutions to the communications, electronics, life sciences and chemical analysis industries. The Company’s operations include electronic measurement, bio-analytical measurement, semiconductor and board testing.
  • Johnson & Johnson (NYSE:JNJ): UBS reiterated its rating of Buy for this company and changed its price target from $74 to $72. About the company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Brookfield Properties (NYSE:BPO): UBS reiterated its rating of Neutral for this company and changed its price target from $19 to $16. About the company: Brookfield Properties Corporation owns, develops, and manages North American office properties. The Company’s portfolio comprises various commercial properties and development sites, including the World Financial Center in New York.
  • NovaGold Resources (AMEX:NG): RBC Capital Mkts reiterated its rating of Sector Perform for this company and changed its price target from $16 to $11. About the company: NovaGold Resources Inc. is a mineral exploration company. The Company, through its subsidiaries, explores and develops mineral properties in North America. NovaGold primarily focuses on gold properties, which may include copper, silver and zinc resources.
  • Manitowoc (NYSE:MTW): RBC Capital Mkts reiterated its rating of Outperform for this company and changed its price target from $27 to $17. About the company: The Manitowoc Company, Inc. is a diversified industrial manufacturer of cranes and related products and foodservice equipment. The Company’s products include lattice-boom cranes, tower cranes, mobile telescopic cranes, and boom trucks as well as ice making machines, refrigerators, and freezers.
  • BlackRock (NYSE:BLK): Ticonderoga reiterated its rating of Buy for this company and changed its price target from $225 to $190. About the company: BlackRock, Inc. provides diversified investment management services to institutional clients and to retail investors through various investment vehicles. The Company offers the BlackRock Funds and Blackrock Liquidity Funds, and also provides risk management services to fixed income institutional investors.
  • Franklin Resources (NYSE:BEN): Ticonderoga reiterated its rating of Buy for this company and changed its price target from $135 to $122. About the company: Franklin Resources, Inc. provides investment advisory services to mutual fund, retirement, institutional/separate accounts and high net worth investors. The Company manages various asset classes including domestic, international/global and emerging markets equity, domestic, international and municipal fixed income, money funds, alternative investments, and hedge funds.
  • Magnum Hunter (NYSE:MHR): Wunderlich reiterated its rating of Buy for this company and changed its price target from $4 to $6. About the company: Magnum Hunter Resources Corporation explores for oil and natural gas.
  • Aixtron (NASDAQ:AIXG): Canaccord Genuity reiterated its rating of Sell for this company and changed its price target from $23 to $8. About the company: Aixtron AG engineers and manufactures metal organic chemical vapor deposition (MOCVD) equipment for the semiconductor industry. The Company’s customers use its equipment to produce compound semiconductor layer structures for use in LED, laser, solar cell, transistor, telecommunications, and other applications. Aixtron markets its products worldwide.
  • TriQuint Semi (NASDAQ:TQNT): Kaufman Bros reiterated its rating of Buy for this company and changed its price target from $6.5 to $8. About the company: TriQuint Semiconductor, Inc. designs, develops, manufactures, and markets a variety of high performance analog and mixed signal integrated circuits for the communications markets. The Company utilizes its proprietary gallium arsenide technology to enable its products to overcome the performance barriers of silicon devices in various applications. TriQuint’s products are sold worldwide.
  • EnergySolutions (NYSE:ES): FBR Capital reiterated its rating of Mkt Perform for this company and changed its price target from $7.5 to $6. About the company: EnergySolutions provides technical services to the nuclear industry.
  • Alaska Air (NYSE:ALK): Ticonderoga reiterated its rating of Buy for this company and changed its price target from $81 to $83. About the company: Alaska Air Group, Inc. is an airline holding company. The Company, through its subsidiaries, provides air service to passengers in multiple destinations. Alaska Air also provide freight and mail services, primarily to and within the state of Alaska and on the West Coast.

(Note: Selected financial data are sourced from Briefing.com via the Wall St. Journal. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>